MaxCyte, Inc. (LON:MXCT – Get Free Report) shares passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 1.16 and traded as low as GBX 0.74. MaxCyte shares last traded at GBX 0.79, with a volume of 1,083,973 shares changing hands.
MaxCyte Price Performance
The business’s 50-day moving average price is GBX 1.16 and its 200 day moving average price is GBX 1.40. The company has a market capitalization of £842,684.39, a P/E ratio of -0.02 and a beta of 1.13. The company has a quick ratio of 14.38, a current ratio of 9.81 and a debt-to-equity ratio of 8.59.
About MaxCyte
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.
Featured Stories
- Five stocks we like better than MaxCyte
- Unlocked: Elon Musk’s Next Big IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
- Read this or regret it forever
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
